H. D. de Melker

发表

Pathogen adaptation under imperfect vaccination: implications for pertussis

M. van Boven, F. Mooi, J. Schellekens, 2005, Proceedings of the Royal Society B: Biological Sciences.

Disease Detection or Public Opinion Reflection? Content Analysis of Tweets, Other Social Media, and Online Newspapers During the Measles Outbreak in the Netherlands in 2013

Gerjo Kok, Enny Das, Liesbeth Mollema, 2015, Journal of medical Internet research.

Parental information-seeking behaviour in childhood vaccinations

H. D. de Melker, G. Kok, R. Ruiter, 2013, BMC Public Health.

Systematically Developing a Web-Based Tailored Intervention Promoting HPV-Vaccination Acceptability Among Mothers of Invited Girls Using Intervention Mapping

H. D. de Melker, Hilde M. van Keulen, R. Ruiter, 2018, Front. Public Health.

Effectiveness of a Web-Based Tailored Intervention With Virtual Assistants Promoting the Acceptability of HPV Vaccination Among Mothers of Invited Girls: Randomized Controlled Trial

H. D. de Melker, I. Eekhout, Hilde M. van Keulen, 2017, Journal of medical Internet research.

Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis

J. Schellekens, H. D. de Melker, P. Teunis, 2005, Epidemiology and Infection.

Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis

J. Schellekens, H. D. de Melker, M. Kretzschmar, 2002, Epidemiology and Infection.

Ascertainment of meningococcal disease in Europe.

H. D. de Melker, M. Ramsay, C. Trotter, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared

H. D. de Melker, L. Mollema, I. A. Harmsen, 2015, BMC Medical Research Methodology.

Seasonal patterns in time series of pertussis

F. Mooi, H. D. de Melker, P. Teunis, 2009, Epidemiology and Infection.

An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls

H. D. de Melker, C. Meijer, R. Donken, 2016, Human vaccines & immunotherapeutics.

Space-Time Cluster Analysis of Invasive Meningococcal Disease

H. D. de Melker, N. Nagelkerke, C. Hoebe, 2004, Emerging infectious diseases.

Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.

H. D. de Melker, J. Wallinga, L. Verhoef, 2012, Vaccine.

Why parents refuse childhood vaccination: a qualitative study using online focus groups

H. D. de Melker, G. Kok, R. Ruiter, 2013, BMC Public Health.

Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.

H. D. de Melker, E. Sanders, A. van der Ende, 2016, Vaccine.

Seroepidemiology of High-Risk HPV in HIV-Negative and HIV-Infected MSM: The H2M Study

H. D. de Melker, P. Snijders, H. D. de Vries, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Seroprevalence of Trichodysplasia Spinulosa–associated Polyomavirus

H. D. de Melker, M. Feltkamp, E. van der Meijden, 2011, Emerging infectious diseases.

Assessing the introduction of universal varicella vaccination in the Netherlands.

T. Kimman, H. D. de Melker, H. Boot, 2006, Vaccine.

Infectious Reactivation of Cytomegalovirus Explaining Age- and Sex-Specific Patterns of Seroprevalence

H. D. de Melker, M. Kretzschmar, D. Baarle, 2017, bioRxiv.

The impact of physical distancing measures against COVID-19 transmission on contacts and mixing patterns in the Netherlands: repeated cross-sectional surveys

H. D. de Melker, J. Wallinga, L. Mollema, 2020, medRxiv.

Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting

H. D. de Melker, D. Klinkenberg, R. Pijnacker, 2018, BMC Medicine.

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period

H. D. de Melker, B. van Benthem, J. van Bergen, 2016, BMC Infectious Diseases.

Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands.

H. D. de Melker, A. van der Ende, M. Knol, 2020, Vaccine.

How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.

J. Berkhof, H. D. de Melker, C. Meijer, 2009, Vaccine.

Assessment of vaccine candidates for persons aged 50 and older: a review

H. D. de Melker, P. Krabbe, A. van Lier, 2013, BMC Geriatrics.

A comparison of hepatitis B seroepidemiology in ten European countries

A. Nardone, H. D. de Melker, J. Mossong, 2008, Epidemiology and Infection.

Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared

H. D. de Melker, E. Sanders, L. Schouls, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Anal, Penile, and Oral High-Risk HPV Infections and HPV Seropositivity in HIV-Positive and HIV-Negative Men Who Have Sex with Men

H. D. de Melker, P. Snijders, H. D. de Vries, 2014, PloS one.

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands

H. D. de Melker, E. Hak, M. Knol, 2018, PloS one.

Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge

H. D. de Melker, R. Donken, F. R. van der Klis, 2021, Human vaccines & immunotherapeutics.

Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country

H. D. de Melker, J. Polder, R. D. de Man, 2018, PloS one.

Changes in HPV Seroprevalence from an Unvaccinated toward a Girls-Only Vaccinated Population in the Netherlands

H. D. de Melker, F. R. van der Klis, H. Pasmans, 2020, Cancer Epidemiology, Biomarkers and Prevention.

Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study.

H. D. de Melker, C. Meijer, M. Knol, 2015, Vaccine.

No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM.

H. D. de Melker, C. Meijer, R. Coutinho, 2014, The Journal of infection.

Persistence of immune response following bivalent HPV vaccination: A follow-up study among girls routinely vaccinated with a two-dose schedule.

H. D. de Melker, R. Schepp, R. Donken, 2018, Vaccine.

Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands.

H. D. de Melker, L. Mollema, M. Knol, 2019, Vaccine.

Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.

H. D. de Melker, A. G. Boef, E. Sanders, 2018, Vaccine.

Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.

T. Kimman, H. D. de Melker, H. Boot, 2006, Vaccine.

Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.

H. D. de Melker, J. Kemmeren, N. V. D. van der Maas, 2011, Vaccine.

Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study.

H. D. de Melker, E. Sanders, A. van der Ende, 2018, The Lancet. Infectious diseases.

Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies.

M. van Boven, F. Mooi, H. D. de Melker, 2013, Vaccine.

Assessing the introduction of universal rotavirus vaccination in the Netherlands.

H. D. de Melker, Y. V. van Duynhoven, H. Vennema, 2008, Vaccine.

Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study

H. D. de Melker, P. Krabbe, R. Eilers, 2015, BMC Public Health.

Delayed Start of Diphtheria, Tetanus, Acellular Pertussis and Inactivated Polio Vaccination in Preterm and Low Birth Weight Infants in the Netherlands

H. D. de Melker, A. van Lier, N. V. D. van der Maas, 2014, The Pediatric infectious disease journal.

High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.

H. D. de Melker, Koen Hulshof, F. R. van der Klis, 2020, Vaccine.

Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands

H. D. de Melker, L. Mollema, R. V. Van BInnendijk, 2019, Vaccines.

Attitudes of Dutch general practitioners towards vaccinating the elderly: less is more?

H. D. de Melker, P. Krabbe, R. Eilers, 2015, BMC Family Practice.

Pertussis in infancy and the association with respiratory and cognitive disorders at toddler age.

F. Mooi, H. D. de Melker, J. van de Kassteele, 2011, Vaccine.

Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications.

H. D. de Melker, L. Mollema, A. Kroes, 2015, Journal of Clinical Virology.

[Vaccines against human papillomavirus (HPV); between registration and implementation].

J. Berkhof, H. D. de Melker, M. Kretzschmar, 2008, Nederlandsch tijdschrift voor geneeskunde.

Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands

H. D. de Melker, E. Sanders, L. Schouls, 2010, Emerging infectious diseases.

Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands

H. D. de Melker, L. Mollema, F. R. van der Klis, 2019, BMC Infectious Diseases.

Antibodies to Haemophilus influenzae serotype b in the Netherlands a few years after the introduction of routine vaccination.

H. D. de Melker, S. van den Hof, G. Berbers, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands

H. D. de Melker, E. Sanders, L. Schouls, 2013, Epidemiology and Infection.

Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands.

H. D. de Melker, E. Sanders, A. van der Ende, 2016, Vaccine.

Guillain‐Barré syndrome: background incidence rates in The Netherlands

H. D. de Melker, J. Dieleman, M. Sturkenboom, 2011, Journal of the peripheral nervous system : JPNS.

[Universal vaccination against group C meningococci and pneumococci; advice from the Health Council of the Netherlands].

H. D. de Melker, A. Timen, S. D. de Greeff, 2002, Nederlands tijdschrift voor geneeskunde.

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.

H. D. de Melker, E. Sanders, A. van der Ende, 2019, Vaccine.

Burden of four vaccine preventable diseases in older adults.

H. D. de Melker, M. Kretzschmar, W. van der Hoek, 2016, Vaccine.

Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis

H. D. de Melker, P. Strebel, R. V. Van BInnendijk, 2019, The Lancet. Infectious diseases.

The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years

H. D. de Melker, M. Kretzschmar, J. Wallinga, 2021, European Journal of Epidemiology.

Population-based Toxoplasma seroprevalence study in The Netherlands

H. D. de Melker, I. Veldhuijzen, L. Kortbeek, 2004, Epidemiology and Infection.

Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires

H. D. de Melker, H. Boshuizen, L. Mollema, 2012, BMC Public Health.

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

S. de Lusignan, H. D. de Melker, M. Valenciano, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin

F. Mooi, H. D. de Melker, N. V. D. van der Maas, 2013, Epidemiology and Infection.

Tolerability of 2 doses of pandemic influenza vaccine (Focetria®) and of a prior dose of seasonal 2009-2010 influenza vaccination in the Netherlands

H. D. de Melker, J. Kemmeren, N. V. D. van der Maas, 2016, Human vaccines & immunotherapeutics.

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015

H. D. de Melker, E. Sanders, A. van der Ende, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effects of Prophylactic and Therapeutic Paracetamol Treatment during Vaccination on Hepatitis B Antibody Levels in Adults: Two Open-Label, Randomized Controlled Trials

J. Pennings, R. Janssen, H. van Loveren, 2014, PloS one.

Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands.

H. D. de Melker, A. Steens, A. van Lier, 2012, Vaccine.

Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls.

S. H. van der Burg, H. D. de Melker, M. Welters, 2019, Vaccine.

Effect of vaccination on severity and infectiousness of measles during an outbreak in the Netherlands, 2013–2014

H. D. de Melker, J. Wallinga, S. Hahné, 2020, Epidemiology and Infection.

Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands

H. D. de Melker, A. van der Ende, N. V. van Sorge, 2022, medRxiv.

Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care

H. Goossens, H. D. de Melker, C. Butler, 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?

F. Mooi, H. D. de Melker, G. Berbers, 2013, Vaccine.

Specificity and Sensitivity of High Levels of Immunoglobulin G Antibodies against Pertussis Toxin in a Single Serum Sample for Diagnosis of Infection with Bordetella pertussis

J. Schellekens, H. D. de Melker, L. Elvers, 2000, Journal of Clinical Microbiology.

Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.

H. D. de Melker, J. Kemmeren, N. V. D. van der Maas, 2011, Vaccine.

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study

H. D. de Melker, E. Sanders, A. van der Ende, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018

H. D. de Melker, E. Sanders, A. van der Ende, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Healthcare costs attributable to congenital cytomegalovirus infection

H. D. de Melker, M. Marle, A. Vossen, 2018, Archives of Disease in Childhood.

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule

J. Berkhof, H. D. de Melker, J. Bogaards, 2021, The Journal of infectious diseases.

Seroprevalence of seven high-risk HPV types in The Netherlands.

H. D. de Melker, C. Meijer, H. Boot, 2012, Vaccine.

Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus.

M. van Boven, H. D. de Melker, A. Pugliese, 2017, Epidemics.

The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

H. D. de Melker, H. Boot, S. van den Hof, 2006, Vaccine.

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

H. D. de Melker, H. Boot, A. V. van Hoek, 2010, BMC health services research.

Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys

H. D. de Melker, I. A. Harmsen, A. van Lier, 2016, BMC Infectious Diseases.

A population-based study on tetanus antitoxin levels in The Netherlands.

H. D. de Melker, N. Nagelkerke, S. van den Hof, 1999, Vaccine.

Rubella Outbreak in the Netherlands, 2004–2005: High Burden of Congenital Infection and Spread to Canada

H. D. de Melker, T. Mazzulli, R. V. Van BInnendijk, 2009, The Pediatric infectious disease journal.

Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.

H. D. de Melker, S. van den Hof, G. Berbers, 2003, Vaccine.

Immunity to poliomyelitis in The Netherlands.

T. Kimman, H. D. de Melker, M. C. Conyn-van Spaendonck, 2001, American journal of epidemiology.

Mumps Vaccine Effectiveness Against Orchitis

H. D. de Melker, R. V. Van BInnendijk, C. Swaan, 2012, Emerging infectious diseases.

Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia.

H. D. de Melker, E. Sanders, A. van der Ende, 2017, Vaccine.

Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.

T. Kimman, H. D. de Melker, M. Koopmans, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

H. D. de Melker, E. Sanders, A. van der Ende, 2015, Emerging infectious diseases.

[High vaccination coverage of the National Immunization Programme in the Netherlands].

H. D. de Melker, P. Oomen, M. W. Oostenbrug, 2009, Nederlands tijdschrift voor geneeskunde.

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004–2016

H. D. de Melker, A. van der Ende, M. Knol, 2019, BMC Infectious Diseases.

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018

H. D. de Melker, A. van der Ende, M. Knol, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.

H. D. de Melker, A. van der Ende, M. Knol, 2017, The Lancet. Public health.

Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study

M. van Boven, H. D. de Melker, E. Sanders, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands

H. D. de Melker, A. van Lier, R. Akkermans, 2021, BMC Public Health.

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

H. D. de Melker, R. Veenhoven, E. Sanders, 2013, JAMA.

Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020.

H. D. de Melker, E. Sanders, M. Knol, 2021, Vaccine.

A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021

H. D. de Melker, J. Wallinga, K. Ainslie, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine

H. D. de Melker, E. Sanders, L. Mollema, 2010, PloS one.

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.

F. Mooi, J. Schellekens, H. D. de Melker, 1997, Emerging infectious diseases.

Asymptomatic infection and transmission of pertussis in households: a systematic review.

H. D. de Melker, B. Althouse, S. Scarpino, 2019, Clinical Infectious Diseases.

Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin.

H. D. de Melker, F. Versteegh, S. D. de Greeff, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination

H. D. de Melker, E. Sanders, A. Buisman, 2017, The Pediatric infectious disease journal.

Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination

H. D. de Melker, C. Meijer, G. Berbers, 2013, Human vaccines & immunotherapeutics.

Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands

H. D. de Melker, J. van der Lei, M. Sturkenboom, 2014, European Journal of Pediatrics.

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology

H. D. de Melker, J. Wallinga, E. Sanders, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines

H. D. de Melker, M. Postma, J. Wilschut, 2018, BMC Medicine.

Age-specific HPV seroprevalence among young females in The Netherlands

H. D. de Melker, L. Mollema, H. Boot, 2010, Sexually Transmitted Infections.

Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.

F. Mooi, H. D. de Melker, A. Lugnér, 2009, Vaccine.

Immunosurveillance and the evaluation of national immunization programmes: a population-based approach.

H. D. de Melker, M. C. Conyn-van Spaendonck, 1998, Epidemiology and infection.

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022

H. D. de Melker, M. Knol, S. McDonald, 2022, medRxiv.

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

H. D. de Melker, S. van den Hof, G. Berbers, 1999, Vaccine.

Prevalence of antibodies against rubella virus in the Netherlands 9 years after changing from selective to mass vaccination

H. D. de Melker, S. van den Hof, G. Berbers, 1999, Epidemiology and Infection.

Factors That Influence Vaccination Decision-Making by Parents Who Visit an Anthroposophical Child Welfare Center: A Focus Group Study

H. D. de Melker, G. Kok, R. Ruiter, 2012, Advances in preventive medicine.

Optimizing the use of the Men-ACWY conjugated vaccine to control the developing meningococcal W disease outbreak in the Netherlands, a rapid analysis

H. D. de Melker, J. Wallinga, M. Knol, 2018 .

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study.

H. D. de Melker, J. van de Kassteele, M. Rondy, 2010, Vaccine.

Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.

J. Berkhof, T. Kimman, H. D. de Melker, 2007, Vaccine.

Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

M. van Boven, H. D. de Melker, L. Mollema, 2020, Journal of Epidemiology & Community Health.

Impact of physical distancing measures against COVID-19 on contacts and mixing patterns: repeated cross-sectional surveys, the Netherlands, 2016–17, April 2020 and June 2020

H. D. de Melker, J. Wallinga, L. Mollema, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands

M. van Boven, H. D. de Melker, J. Wallinga, 2021, European Journal of Epidemiology.

Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands

M. van Boven, H. D. de Melker, H. Boshuizen, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands

H. D. de Melker, L. Mollema, R. V. Van BInnendijk, 2021, medRxiv.

Vaccine preferences and acceptance of older adults.

H. D. de Melker, J. Veldwijk, P. Krabbe, 2017, Vaccine.

Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis.

H. D. de Melker, S. Desai, I. Veldhuijzen, 2021, Vaccine.

Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021

H. D. de Melker, N. V. van Sorge, A. Steens, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Acute cerebellar ataxia in the Netherlands: a study on the association with vaccinations and varicella zoster infection.

H. D. de Melker, J. Kemmeren, N. V. D. van der Maas, 2009, Vaccine.

Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence

H. D. de Melker, R. V. Van BInnendijk, A. Kroes, 2015, Epidemiology and Infection.

Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women.

H. D. de Melker, M. Feltkamp, C. Meijer, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Immunisation of migrants in EU/EEA countries: Policies and practices.

H. D. de Melker, V. Saliba, D. Levy-bruhl, 2019, Vaccine.

Congenital Cytomegalovirus Infection: Child Development, Quality of Life and Impact on Daily Life

H. D. de Melker, A. Kroes, A. Vossen, 2017, The Pediatric infectious disease journal.

Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: children of Chinese mothers are at increased risk of breakthrough infection.

H. D. de Melker, H. Boot, A. van den Hoek, 2012, Vaccine.

Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020

H. D. de Melker, E. Sanders, N. V. van Sorge, 2021, Vaccine.

Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007

H. D. de Melker, M. Kretzschmar, L. Mollema, 2011, Epidemiology and Infection.

Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996–2008

H. D. de Melker, M. Sturkenboom, E. M. Soest, 2012, Neuroepidemiology.

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

M. van Boven, H. D. de Melker, R. V. Van BInnendijk, 2022, Vaccine.

Seropositivity to Nucleoprotein to detect SARS-CoV-2 infections: a tool to detect breakthrough infections after COVID-19 vaccination

M. van Boven, H. D. de Melker, C. Reusken, 2021, medRxiv.

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

J. Singer, H. D. de Melker, C. Meijer, 2020, BMC Infectious Diseases.

Persisting Antibody Response Nine Years after Bivalent HPV Vaccination in A Cohort of Dutch Women: Immune Response and the Relation with Genital HPV Infections.

H. D. de Melker, M. Knol, R. Schepp, 2020, The Journal of infectious diseases.

HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model‐based cost‐effectiveness

J. Berkhof, H. D. de Melker, P. Snijders, 2009, International journal of cancer.

MenACWY vaccination campaign for adolescents in the Netherlands: Uptake and its determinants.

H. D. de Melker, M. Knol, A. van Lier, 2020, Vaccine.

Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles

H. D. de Melker, R. V. Van BInnendijk, R. D. de Swart, 2019, Vaccines.

The tip of the iceberg: incompleteness of measles reporting during a large outbreak in The Netherlands in 2013–2014

H. D. de Melker, J. Wallinga, R. V. Van BInnendijk, 2018, Epidemiology and Infection.

Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study

H. D. de Melker, L. Mollema, G. Berbers, 2016, PloS one.

Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin

H. D. de Melker, A. Lugnér, A. Suijkerbuijk, 2022 .

Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage.

H. D. de Melker, L. Mollema, G. Berbers, 2014, Vaccine.

Vaccine uptake determinants in The Netherlands.

H. D. de Melker, J. van de Kassteele, A. van Lier, 2014, European journal of public health.

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.

H. D. de Melker, L. Mollema, H. van der Avoort, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Large ongoing measles outbreak in a religious community in the Netherlands since May 2013.

H. D. de Melker, L. Mollema, A. Timen, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands

H. D. de Melker, L. Mollema, R. V. Van BInnendijk, 2013, Epidemiology and Infection.

Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009.

H. D. de Melker, R. V. Van BInnendijk, H. Boot, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

F. Mooi, J. Schellekens, H. D. de Melker, 2010, PloS one.

High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study.

H. D. de Melker, L. Mollema, A. Steens, 2010, Vaccine.

Second national serum bank for population-based seroprevalence studies in the Netherlands.

H. D. de Melker, L. Mollema, G. Berbers, 2009, The Netherlands journal of medicine.

Mumps in a community with low vaccination coverage in the Netherlands.

H. D. de Melker, R. V. Van BInnendijk, A. van Lier, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.

H. D. de Melker, M. Koopmans, H. T. ten Hulscher, 2016, Vaccine.

Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.

H. D. de Melker, G. Freidl, E. Duizer, 2018, Vaccine.

Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012

H. D. de Melker, M. Sturkenboom, S. Straus, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The seroepidemiology of measles in Western Europe

France, Finland., J. Schellekens, 2001, Epidemiology and Infection.

The seroepidemiology of herpes simplex virus type 1 and 2 in Europe

H. D. de Melker, P. van Damme, R. Pebody, 2004, Sexually Transmitted Infections.

Valganciclovir for Congenital Cytomegalovirus.

H. D. de Melker, J. D. de Vries, M. Korndewal, 2015, The New England journal of medicine.

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012

H. D. de Melker, M. Koopmans, R. V. Van BInnendijk, 2014, Emerging infectious diseases.

Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis

H. D. de Melker, W. Moss, P. Strebel, 2019, The Lancet. Infectious diseases.

The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.

E. L. Miller, R Vranckx, A. Nardone, 2007, Vaccine.

Response to Lim et al regarding "In-flight transmission of measles: Time to update the guidelines?"

H. D. de Melker, C. Swaan, S. Hahné, 2017, American journal of infection control.

Two-Component Cluster Analysis of a Large Serodiagnostic Database for Specificity of Increases of IgG Antibodies against Pertussis Toxin in Paired Serum Samples and of Absolute Values in Single Serum Samples

F. Mooi, J. Schellekens, H. D. de Melker, 2012, Clinical and Vaccine Immunology.

Seroprevalence of Pertussis in The Gambia

F. Mooi, H. D. de Melker, S. Scott, 2015, The Pediatric infectious disease journal.

Pertussis disease burden in the household: how to protect young infants.

F. Mooi, J. Schellekens, H. D. de Melker, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The seroepidemiology of Bordetella pertussis infection in Western Europe

A. Nardone, J. Schellekens, H. D. de Melker, 2004, Epidemiology and Infection.

PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS

H. D. de Melker, L. Schouls, S. D. de Greeff, 2006, The Pediatric infectious disease journal.

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands

H. D. de Melker, A. G. Boef, E. Sanders, 2017, British Medical Journal.

European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus.

A. Nardone, H. D. de Melker, J. Mossong, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands

H. D. de Melker, J. Wallinga, M. Postma, 2018, Epidemiology and Infection.

Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?

H. D. de Melker, Y. V. van Duynhoven, H. Vennema, 2010, Vaccine.

Measles outbreak, the Netherlands, 2008.

H. D. de Melker, L. Mollema, R. V. Van BInnendijk, 2010, Emerging infectious diseases.

Population- and type-specific clustering of multiple HPV types across diverse risk populations in the Netherlands.

H. J. Vriend, H. D. de Melker, C. Meijer, 2014, American journal of epidemiology.

Factors affecting the uptake of vaccination by the elderly in Western society.

H. D. de Melker, P. Krabbe, R. Eilers, 2014, Preventive medicine.

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands

H. D. de Melker, M. Kretzschmar, E. Sanders, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey

H. D. de Melker, S. van den Hof, M. C. Conyn-van Spaendonck, 2000, Epidemiology and Infection.

SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics

M. van Boven, H. D. de Melker, R. V. Van BInnendijk, 2022, Scientific Reports.

Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls

H. D. de Melker, C. Meijer, M. Knol, 2016, The Journal of infectious diseases.

Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.

H. D. de Melker, M. Feltkamp, C. Meijer, 2012, Cancer epidemiology.

Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program.

H. D. de Melker, E. Sanders, E. Hak, 2005, Vaccine.

A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands

H. D. de Melker, M. F. van der Wal, T. Paulussen, 2017, BMC Public Health.

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands

H. D. de Melker, T. Daemen, A. Tami, 2014, BMC Public Health.

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection

H. J. Vriend, H. D. de Melker, C. Hoebe, 2015, Cancer medicine.

The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases

H. D. de Melker, C. Meijer, G. D. de Wit, 2017, Expert review of vaccines.

Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials.

H. D. de Melker, M. Knol, G. Berbers, 2015, Vaccine.

Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands

H. D. de Melker, C. Meijer, H. Boot, 2012, PloS one.

High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women

H. D. de Melker, C. Meijer, R. Donken, 2018, The Journal of infectious diseases.

An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005–2011

H. D. de Melker, M. Kretzschmar, P. Teunis, 2015, BMC Infectious Diseases.

Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.

H. D. de Melker, J. Wallinga, S. Waaijenborg, 2013, The Journal of infectious diseases.

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

Mirjam Kretzschmar, Peter F M Teunis, J. Schellekens, 2006, The Journal of infection.

Impact of Acellular Pertussis Preschool Booster Vaccination on Disease Burden of Pertussis in The Netherlands

F. Mooi, J. Schellekens, H. D. de Melker, 2008, The Pediatric infectious disease journal.

Estimation of Household Transmission Rates of Pertussis and the Effect of Cocooning Vaccination Strategies on Infant Pertussis

M. van Boven, F. Mooi, J. Schellekens, 2012, Epidemiology.

Diphtheria antitoxin levels in the Netherlands: a population-based study.

H. D. de Melker, N. Nagelkerke, G. Berbers, 1999, Emerging infectious diseases.

Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination.

H. D. de Melker, J. Wallinga, H. Vennema, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004.

H. D. de Melker, L. Mollema, R. V. Van BInnendijk, 2010, Vaccine.

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster

M. van Boven, H. D. de Melker, J. Wallinga, 2015, EBioMedicine.

Low varicella-related consultation rate in the Netherlands in primary care data.

H. D. de Melker, M. Sturkenboom, G. Donker, 2014, Vaccine.

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study

H. D. de Melker, M. Knol, T. Daemen, 2018, BMC Public Health.

Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010.

H. D. de Melker, R. V. Van BInnendijk, K. Greenland, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Mumps transmission in social networks: a cohort study

H. D. de Melker, J. Wallinga, R. V. Van BInnendijk, 2017, BMC Infectious Diseases.

Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students

H. D. de Melker, M. Koopmans, R. V. Van BInnendijk, 2014, Open forum infectious diseases.

Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks

H. D. de Melker, S. Waaijenborg, L. Mollema, 2013, PloS one.

Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010.

H. D. de Melker, T. Donker, R. V. Van BInnendijk, 2012, Vaccine.

Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008.

H. D. de Melker, J. van de Kassteele, R. V. Van BInnendijk, 2012, Vaccine.

Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay

H. D. de Melker, S. van den Hof, G. Berbers, 2003, Epidemiology and Infection.

Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalence

Mirjam Kretzschmar, Michiel van Boven, Debbie van Baarle, 2017, bioRxiv.

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands

H. D. de Melker, E. Sanders, G. Berbers, 2021, The Lancet regional health. Europe.

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

F. Mooi, J. Schellekens, H. D. de Melker, 2000, Emerging infectious diseases.

Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.

H. D. de Melker, J. van de Kassteele, E. Sanders, 2017, Vaccine.

Maternal vaccination against pertussis as part of the national immunization program: a qualitative evaluation among obstetric care providers one year after the implementation in December 2019

H. D. de Melker, M. Bekker, N. V. D. van der Maas, 2023, BMC Health Services Research.

Social-psychological determinants of maternal pertussis vaccination acceptance during pregnancy among women in the Netherlands.

H. D. de Melker, Hilde M. van Keulen, R. Ruiter, 2020, Vaccine.

[Pertussis in the Netherlands].

F. Mooi, H. D. de Melker, S. D. de Greeff, 2010, Nederlands tijdschrift voor geneeskunde.

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

H. D. de Melker, M. Postma, L. van Alphen, 2004, Vaccine.

Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness

H. D. de Melker, F. Versteegh, N. V. D. van der Maas, 2019, BMC Infectious Diseases.

Risk of Measles and Diphtheria Introduction and Transmission on Bonaire, Caribbean Netherlands, 2018

H. D. de Melker, L. Mollema, Y. Stienstra, 2019, The American journal of tropical medicine and hygiene.

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011

H. D. de Melker, M. Kretzschmar, J. Wallinga, 2016, PloS one.

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

H. D. de Melker, C. Reusken, M. Knol, 2022, Nature Communications.

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021

H. D. de Melker, M. Knol, S. Hahné, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April- August 2021

H. D. de Melker, J. van de Kassteele, N. D. de Keizer, 2021, medRxiv.

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022

H. D. de Melker, M. Knol, S. van den Hof, 2023, medRxiv.

Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study

H. D. de Melker, J. H. van de Wijgert, D. Grobbee, 2023, International Journal of Infectious Diseases.

The effect of previous SARS-CoV-2 infection and COVID-19 vaccination on SARS-CoV-2 Omicron infection and relation with serological response - a prospective cohort study

H. D. de Melker, H. van Werkhoven, M. Knol, 2023, medRxiv.

Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022

H. D. de Melker, I. Van Walle, H. Vennema, 2022, medRxiv.

Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis.

H. D. de Melker, J. Wallinga, M. Postma, 2016, The Lancet. Infectious diseases.

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021

H. D. de Melker, Anita Shah, M. Knol, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The impact of vaccinating adolescents and children on COVID-19 disease outcomes

H. D. de Melker, P. de Boer, K. Y. Leung, 2021, medRxiv.

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021

H. D. de Melker, J. van de Kassteele, M. Knol, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022

H. D. de Melker, C. Reusken, M. Knol, 2022, medRxiv.

SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population

M. van Boven, H. D. de Melker, R. V. Van BInnendijk, 2021, medRxiv.

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

H. D. de Melker, J. H. van de Wijgert, M. Knol, 2023, medRxiv.

Transmissibility of SARS-CoV-2 among fully vaccinated individuals

H. D. de Melker, M. Knol, S. van den Hof, 2021, The Lancet Infectious Diseases.

An exploratory qualitative assessment of factors influencing childhood vaccine providers' intention to recommend immunization in the Netherlands

H. D. de Melker, L. Mollema, T. Paulussen, 2012, BMC Public Health.

A model based evaluation of the 1996–7 pertussis epidemic in the Netherlands

M. van Boven, J. Schellekens, H. D. de Melker, 2001, Epidemiology and Infection.

Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands.

M. van Boven, J. Schellekens, H. D. de Melker, 2000, Mathematical biosciences.

Estimating the Population-Level Effectiveness of Vaccination Programs in the Netherlands

H. D. de Melker, J. Wallinga, M. Postma, 2017, Epidemiology.

Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.

H. D. de Melker, C. Meijer, M. Knol, 2015, The Journal of infection.

The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older

H. D. de Melker, L. Mollema, J. Ferreira, 2017, BMC Geriatrics.

Vaccination decision-making of immigrant parents in the Netherlands; a focus group study

H. D. de Melker, G. Kok, R. Ruiter, 2015, BMC Public Health.

Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6–14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study

H. D. de Melker, M. Knol, R. V. Van BInnendijk, 2017, The Journal of infectious diseases.

Severe underestimation of pertussis related hospitalizations and deaths in the Netherlands: A capture-recapture analysis.

H. D. de Melker, E. Sanders, N. V. D. van der Maas, 2017, Vaccine.

Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.

J. Berkhof, H. D. de Melker, C. Meijer, 2013, American journal of epidemiology.

Approaches to Estimating Clearance Rates for Human Papillomavirus Groupings: A Systematic Review and Real Data Examples

H. D. de Melker, C. J. Alberts, M. F. Schim van der Loeff, 2022, Epidemiology.

Estimation of minimum infection rates with Legionella pneumophila in an exposed population

J. Schellekens, H. D. de Melker, N. Nagelkerke, 2005, Epidemiology and Infection.

Estimating the incidence of subclinical infections with Legionella Pneumonia using data augmentation: analysis of an outbreak in The Netherlands

J. Schellekens, H. D. de Melker, N. Nagelkerke, 2003, Statistics in medicine.

Long‐term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study

H. D. de Melker, M. V. D. van der Sande, A. Kroes, 2017, Developmental medicine and child neurology.

Review: Current knowledge on the role of HPV antibodies after natural infection and vaccination: Implications for monitoring an HPV vaccination programme

H. D. de Melker, C. Meijer, F. R. van der Klis, 2013, Journal of medical virology.

Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects

J. Berkhof, I. Molenaar, H. D. de Melker, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females

H. D. de Melker, C. Meijer, R. Donken, 2019, PloS one.

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors

I. Molenaar, H. D. de Melker, C. Hoebe, 2017, The Journal of infectious diseases.

Informed decision making in the context of childhood immunization.

H. D. de Melker, D. Timmermans, L. Mollema, 2017, Patient education and counseling.

Rubella outbreak in an unvaccinated religious community in the Netherlands spreads to Canada.

H. D. de Melker, R. V. Van BInnendijk, A. King, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Large ongoing rubella outbreak in religious community in the Netherlands since September 2004.

H. D. de Melker, R. V. Van BInnendijk, S. Hahné, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study

H. D. de Melker, M. Knol, M. V. D. van der Sande, 2015, BMC Infectious Diseases.

Intention to vaccinate universally against varicella, rotavirus gastroenteritis, meningococcal B disease and seasonal influenza among parents in the Netherlands: an internet survey

H. D. de Melker, E. Sanders, L. Mollema, 2017, BMC Research Notes.

Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022

H. D. de Melker, N. V. van Sorge, M. Hooiveld, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Varicella zoster virus infection occurs at a relatively young age in The Netherlands.

H. D. de Melker, J. Wallinga, S. Waaijenborg, 2013, Vaccine.

Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment

H. D. de Melker, J. Hontelez, S. Hahné, 2009, Journal of Epidemiology & Community Health.

Præventis, the immunisation register of the Netherlands: a tool to evaluate the National Immunisation Programme.

H. D. de Melker, A. van Lier, J. Kemmeren, 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Parental attitude towards childhood HBV vaccination in The Netherlands.

H. D. de Melker, J. Hontelez, S. Hahné, 2010, Vaccine.

HPV Seroconversion Following Anal and Penile HPV Infection in HIV-Negative and HIV-Infected MSM

H. D. de Melker, P. Snijders, T. Heijman, 2014, Cancer Epidemiology, Biomarkers & Prevention.

The burden of invasive meningococcal disease in the Netherlands, 2011-2020.

H. D. de Melker, N. V. van Sorge, A. Steens, 2023, Vaccine.

A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.

H. D. de Melker, A. van Lier, S. Hahné, 2017, Vaccine.

Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014

H. D. de Melker, N. V. D. van der Maas, S. Hahné, 2015, The Journal of infectious diseases.

Hospitalizations during a measles epidemic in the Netherlands, 1999 to 2000

H. D. de Melker, S. van den Hof, J. V. van Steenbergen, 2002, The Pediatric infectious disease journal.

Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study

H. D. de Melker, J. Kemmeren, A. Kant, 2021, BMC Public Health.

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands

H. D. de Melker, A. G. Boef, D. van Baarle, 2018, Front. Public Health.

Socio-psychological determinants of second trimester maternal pertussis vaccination acceptance in the Netherlands.

H. D. de Melker, M. Bekker, N. V. D. van der Maas, 2023, Vaccine.

Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants

H. D. de Melker, E. Sanders, M. Bekker, 2021, BMC Infectious Diseases.

Background incidence rates of adverse pregnancy outcomes in the Netherlands: Data of 2006-2018.

H. D. de Melker, F. Groenendaal, M. Bekker, 2020, European journal of obstetrics, gynecology, and reproductive biology.

Non-participation in a population-based seroprevalence study of vaccine-preventable diseases

H. D. de Melker, M. C. Conyn-van Spaendonck, N. J. Nagelkerde, 2000, Epidemiology and Infection.

Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era

H. D. de Melker, L. Mollema, M. Knol, 2016, PloS one.

Performance of a bedside test for tetanus immunity: results of a cross-sectional study among three EDs in the Netherlands in 2012–2013

H. D. de Melker, C. Swaan, N. V. D. van der Maas, 2016, Emergency Medicine Journal.

The use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: a cross-sectional questionnaire study

H. D. de Melker, C. Swaan, T. Wiersma, 2014, BMC Family Practice.

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands

H. D. de Melker, E. Sanders, L. Schouls, 2012, Emerging infectious diseases.

How to increase awareness of additional vaccinations; the case of maternal pertussis vaccination

H. D. de Melker, L. Mollema, M. Bongers, 2021, BMC Public Health.

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022

H. D. de Melker, M. Knol, S. van den Hof, 2023, Vaccine.

Measles outbreak in a community with very low vaccine coverage, the Netherlands.

H. D. de Melker, R. V. Van BInnendijk, S. van den Hof, 2001, Emerging infectious diseases.

Hospitalization due to varicella in the Netherlands

H. D. de Melker, E. Sanders, A. van Lier, 2011, BMC infectious diseases.

Two doses of pandemic influenza A(H1N1) vaccine: Tolerability in healthy young children in the Netherlands

H. D. de Melker, J. Kemmeren, N. V. D. van der Maas, 2011, Human vaccines.

[The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients].

H. D. de Melker, J. Dankert, S. van den Hof, 2003, Nederlands tijdschrift voor geneeskunde.

Determinants of COVID-19 vaccine uptake in the Netherlands: an ecological analysis

H. D. de Melker, J. van de Kassteele, B. Bom, 2023, medRxiv.

COVID-19 vaccine effectiveness against mortality and risk of death from other causes after COVID-19 vaccination, the Netherlands, January 2021- January 2022

H. D. de Melker, H. van Werkhoven, M. Knol, 2022, medRxiv.

Age-specific severity of SARS-CoV-2 in February 2020 - June 2021 in the Netherlands

H. D. de Melker, J. van de Kassteele, D. Dongelmans, 2023, medRxiv.

High varicella-zoster virus susceptibility in Caribbean island populations: implications for vaccination.

M. van Boven, H. D. de Melker, L. Mollema, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.

H. D. de Melker, M. Sturkenboom, J. Kemmeren, 2018, Vaccine.

Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared

H. D. de Melker, E. Sanders, L. Schouls, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands.

H. D. de Melker, E. Sanders, M. Bekker, 2023, Vaccine.

Is there an association between socioeconomic status and immune response to infant and childhood vaccination in the Netherlands?

H. D. de Melker, M. Knol, J. Van den Boogaard, 2020, Vaccine.

Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.

H. D. de Melker, J. van de Kassteele, H. Vennema, 2021, Vaccine.

Psychosocial determinants of parents' intention to vaccinate their newborn child against hepatitis B.

H. D. de Melker, G. Kok, R. Ruiter, 2012, Vaccine.

Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes.

H. D. de Melker, E. Sanders, A. van der Ende, 2016, Future microbiology.

Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: Implications for future impact on prevention

H. D. de Melker, H. Boshuizen, A. Steens, 2013, International journal of cancer.

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

H. D. de Melker, C. Reusken, M. Knol, 2022, Nature Communications.

Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology

H. D. de Melker, M. Knol, S. van den Hof, 2023, Nature communications.

Determinants of COVID-19 vaccine uptake in the Netherlands: a nationwide registry-based study

H. D. de Melker, J. Pijpers, S. Hahné, 2023, medRxiv.

The daily updated Dutch national database on COVID-19 epidemiology, vaccination and sewage surveillance

M. van Boven, H. D. de Melker, I. Van Walle, 2023, Scientific data.

Clinical Characterization of Invasive Disease Caused by Haemophilus influenzae Serotype b in a High Vaccination Coverage Setting.

H. D. de Melker, E. Sanders, A. van der Ende, 2019, Journal of the Pediatric Infectious Diseases Society.

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology

H. D. de Melker, J. Wallinga, W. Ruijs, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominanceof Delta variant (B.1.617.2), August-September 2021, the Netherlands

H. D. de Melker, M. Knol, S. Hahné, 2021, medRxiv.

Seroprevalence of Pertussis in The Gambia

F. Mooi, H. D. de Melker, S. Scott, 2015, The Pediatric Infectious Disease Journal.

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

F. Mooi, J. Schellekens, H. D. de Melker, 2010, PloS one.

Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin.

H. D. de Melker, F. Versteegh, S. D. de Greeff, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Acellular Pertussis Preschool Booster Vaccination on Disease Burden of Pertussis in The Netherlands

F. Mooi, J. Schellekens, H. D. de Melker, 2008, The Pediatric infectious disease journal.

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors

H. D. de Melker, Van Benthem, V. D. Klis, 2018 .

Background incidence rates of adverse pregnancy outcomes in the Netherlands: Data of 2006-2018.

H. D. de Melker, F. Groenendaal, M. Bekker, 2020, European journal of obstetrics, gynecology, and reproductive biology.

Review of outbreaks and barriers to MMR vaccination coverage among hard-to-reach populations in Europe

Svetla, H. D. de Melker, P. Lopalco, 2013 .

No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM.

H. D. de Melker, C. Meijer, R. Coutinho, 2014, The Journal of infection.

Population- and type-specific clustering of multiple HPV types across diverse risk populations in the Netherlands.

H. J. Vriend, H. D. de Melker, C. Meijer, 2014, American journal of epidemiology.

Review: Current knowledge on the role of HPV antibodies after natural infection and vaccination: Implications for monitoring an HPV vaccination programme

H. D. de Melker, C. Meijer, F. R. van der Klis, 2013, Journal of medical virology.

Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.

H. D. de Melker, J. Kemmeren, N. V. D. van der Maas, 2011, Vaccine.

Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia.

H. D. de Melker, E. Sanders, A. van der Ende, 2017, Vaccine.

Space-Time Cluster Analysis of Invasive Meningococcal Disease

H. D. de Melker, C. Hoebe, L. Spanjaard, 2004, Emerging infectious diseases.

Immune response following a two-dose schedule of bivalent HPV vaccination among girls and boys

H. D. de Melker, J. van de Kassteele, J. Duijster, 2024, Frontiers in immunology.

H. D. de Melker, A. V. van Hoek, E. Vos, 2024, PLoS ONE.

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands

J. Berkhof, H. D. de Melker, A. Siebers, 2023, Cancer medicine.

Low varicella-related consultation rate in the Netherlands in primary care data.

H. D. de Melker, M. Sturkenboom, G. Donker, 2014, Vaccine.